98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1590/0102-311x00170019 | DOI Listing |
Indian J Pharmacol
September 2025
Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Dermatol Pract Concept
July 2025
Department of Dermatology, Venereology & Leprosy, Atul Bihari Vajpayee Institute of Medical sciences & Dr. Ram Manohar Lohia Hospital, New Delhi, India.
PLoS Negl Trop Dis
August 2025
Department of Global Health, Institute of Public Health and Nursing Research, University of Bremen, Bremen, Germany.
Background: Leprosy elimination has recently re-entered the global health sphere, with the World Health Organisation's (WHO) "Towards zero leprosy" strategy (2021-2030). Previously, its elimination had been defined as a prevalence of less than 1 case per 10,000, which was achieved on a global scale in 2000, leading to a large withdrawal of resources from leprosy control and to neglect on both global and national scales. Despite this, leprosy continued to spread and affect hundreds of thousands of people annually.
View Article and Find Full Text PDFInfect Dis Poverty
August 2025
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Background: The importance of patient participation in designing and delivering services for persons affected by neglected tropical diseases (NTDs) has gained increasing recognition. Responding to this, persons affected by NTDs urged NTD-focused non-governmental organisations (NGOs) to take action. These NGOs are pivotal in addressing healthcare disparities and reaching marginalised communities.
View Article and Find Full Text PDFBMJ Open
July 2025
Clinical Studies and Trials Unit, Division of Development Research, Indian Council of Medical Research, Ministry of Health and Family Welfare, New Delhi, India.
Introduction: Using the community-based participatory research (CBPR) methodology, sustained peer group treatment has effectively improved medication adherence. Although many studies investigate the effectiveness of peer group therapy, there is a lack of evidence addressing the cost-effectiveness of CBPR models in low- and middle-income countries. This protocol outlines the methods for the economic evaluation of the PArticipatory Research model for medicaTIon adherenCe In People with diAbetes and hyperTEnsion (PARTICIPATE) trial to determine whether the CBPR approach to enhance medication adherence among patients with diabetes and/or hypertension is cost-effective in India.
View Article and Find Full Text PDF